Basic Information
ID: ALA3299365
Type: ADME
Description: Drug level in human CaSki cells treated with ethyl 7-[4-(1,3-Benzothiazol-2-yl)piperazin-1-yl]-1-(3-chloro-2- fluorobenzyl)-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylate at 10 uM after 16 hrs by reverse-phase HPLC analysis
Organism: Homo sapiens
Cell type: Ca-Ski
Activity Charts
Bioactivity
Activity Types for Assay ALA3299365
Drug metabolism
Compound Summary
| Parent Molecular Weight | ALogP | Polar Surface Area |
|---|---|---|
| 578.07 | 5.35 | 5.35 |